Skip to content

Disc Medicine IRON Operating Income

Discontinued — last reported Q1 '26

Operating Income at other companies

Vertex Pharmaceuticals logo
Vertex PharmaceuticalsVRTX
$1.14B+80.6%
Protagonist Therapeutics logo
Protagonist TherapeuticsPTGX
-$3.65M+81.1%
Agios Pharmaceuticals logo
Agios PharmaceuticalsAGIO
-$110.03M-3.2%
Beam Therapeutics logo
Beam TherapeuticsBEAM
-$107.22M+10.1%
Travere Therapeutics, Inc. logo
Travere Therapeutics, Inc.TVTX
-$36.92M+13.5%
BridgeBio Pharma logo
BridgeBio PharmaBBIO
-$105.96M-1.5%

Other financials

Income statement

See full
Net income-$63.5M-86.3%
EPS (diluted)-$1.65-61.8%

Balance sheet

See full
Cash & equivalents$88.9M-27.5%
Total debt$31.1M+1.4%
Total equity$688.4M+4.3%
Total assets$750.2M+5.8%

Cash flow

See full
Operating cash flow-$62.2M-50.4%
CapEx--100%
Free cash flow-$62.2M-47.4%

Valuation

See full
Market cap$2.69B+42.2%
Enterprise value$2.63B+46.7%

Returns & leverage

See full
Return on equity-35.8%+41.3pp
Debt / equity0.0×
Current ratio24×-13.6×

Where this comes from

Reported directly by Disc Medicine in its filing.

Tagged under the XBRL concept us-gaap:OperatingIncomeLoss.

The official record: Disc Medicine’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →

Ask your AI about Disc Medicine's operating income.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Disc Medicine's operating income?
Disc Medicine (IRON) reported operating income of -$69.52M in Q1 2026.
How has Disc Medicine's operating income changed year-over-year?
Disc Medicine's operating income decreased by 74.0% year-over-year, from -$39.95M to -$69.52M.
What is the long-term trend for Disc Medicine's operating income?
Over 3 years (2022 to 2025), Disc Medicine's operating income has grown at a 70.7% compound annual growth rate (CAGR), from -$47.48M to -$236.02M.
What does operating income mean?
Gross profit minus all operating expenses (SG&A, R&D, D&A). Measures the profit from core business operations before interest, taxes, and non-operating items.